Literature DB >> 15380564

Selective and persistent upregulation of mdr1b mRNA and P-glycoprotein in the parahippocampal cortex of chronic epileptic rats.

Erwin van Vliet1, Eleonora Aronica, Sandra Redeker, Nicola Marchi, Massimo Rizzi, Annamaria Vezzani, Jan Gorter.   

Abstract

There is recent evidence that increased expression of multidrug transporters, such as P-glycoprotein (P-gp), may lead to reduced antiepileptic drug (AED) concentrations in the brain, shortly after status epilepticus (SE), thereby suggesting a possible mechanism for drug-resistance. To get insights on whether increased P-gp expression is a consequence of the initial insult, or evolves more gradually as a result of recurrent spontaneous seizures, we used a rat model of temporal lobe epilepsy in which spontaneous seizures develop after an electrically induced SE. We investigated the temporal and region-specific expression of two isoforms of the multidrug resistance gene (mdr1a and mdr1b, both encoding for P-gp) in two regions within the temporal lobe (the dentate gyrus (DG) and the parahippocampal cortex (PHC)). Using real-time PCR, we found that the mdr1b isoform was increased in the temporal lobe, 1 week after SE; however, this increase was reversible in dentate gyrus while it persisted in the parahippocampal cortex of chronic epileptic rats. Mdr1b upregulation was related to the occurrence of spontaneous seizures, since this isoform was unchanged in rats that were stimulated, but that did not develop SE (non-SE). The mdr1a isoform was transiently upregulated in the dentate gyrus. P-gp immunostaining was enhanced in endothelial and glia-like cells, 1 week after SE. In chronic epileptic rats, the number of strongly P-gp positive glia-like cells was much lower than 1 week after SE, and it was mainly present in the most ventral part of the temporal lobe. These cells were in close apposition to strongly stained blood vessels. These findings show that both mdr1a and mdr1b are induced by SE, although the increase in mdr1b isoform was more persistent. More importantly, increased P-gp expression is still present in chronic epileptic rats.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15380564     DOI: 10.1016/j.eplepsyres.2004.06.005

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  10 in total

1.  Alteration in P-glycoprotein functionality affects intrabrain distribution of quinidine more than brain entry-a study in rats subjected to status epilepticus by kainate.

Authors:  Stina Syvänen; Maarten Schenke; Dirk-Jan van den Berg; Rob A Voskuyl; Elizabeth C de Lange
Journal:  AAPS J       Date:  2012-01-04       Impact factor: 4.009

2.  Cellular localization and functional significance of CYP3A4 in the human epileptic brain.

Authors:  Chaitali Ghosh; Nicola Marchi; Nirav K Desai; Vikram Puvenna; Mohammed Hossain; Jorge Gonzalez-Martinez; Andreas V Alexopoulos; Damir Janigro
Journal:  Epilepsia       Date:  2011-02-05       Impact factor: 5.864

Review 3.  Management of the patient with medically refractory epilepsy.

Authors:  Tiziana Granata; Nicola Marchi; Erin Carlton; Chaitali Ghosh; Jorge Gonzalez-Martinez; Andreas V Alexopoulos; Damir Janigro
Journal:  Expert Rev Neurother       Date:  2009-12       Impact factor: 4.618

4.  Reduced antidiabetic effect of metformin and down-regulation of hepatic Oct1 in rats with ethynylestradiol-induced cholestasis.

Authors:  Hyo-Eon Jin; Soon-Sun Hong; Min-Koo Choi; Han-Joo Maeng; Dae-Duk Kim; Suk-Jae Chung; Chang-Koo Shim
Journal:  Pharm Res       Date:  2008-11-11       Impact factor: 4.200

5.  (R)-[11C]verapamil PET studies to assess changes in P-glycoprotein expression and functionality in rat blood-brain barrier after exposure to kainate-induced status epilepticus.

Authors:  Stina Syvänen; Gert Luurtsema; Carla F M Molthoff; Albert D Windhorst; Marc C Huisman; Adriaan A Lammertsma; Rob A Voskuyl; Elizabeth C de Lange
Journal:  BMC Med Imaging       Date:  2011-01-03       Impact factor: 1.930

6.  The etiological role of blood-brain barrier dysfunction in seizure disorders.

Authors:  Nicola Marchi; William Tierney; Andreas V Alexopoulos; Vikram Puvenna; Tiziana Granata; Damir Janigro
Journal:  Cardiovasc Psychiatry Neurol       Date:  2011-03-30

7.  HMGB1 regulates P-glycoprotein expression in status epilepticus rat brains via the RAGE/NF-κB signaling pathway.

Authors:  Yuan Xie; Nian Yu; Yan Chen; Kang Zhang; Hai-Yan Ma; Qing Di
Journal:  Mol Med Rep       Date:  2017-06-14       Impact factor: 2.952

8.  Involvement of N-Methyl-D-Aspartate Receptors in the Anticonvulsive Effects of Licofelone on Pentylenetetrazole-Induced Clonic Seizure in Mice.

Authors:  Ramtin Gholizadeh; Zohreh Abdolmaleki; Taraneh Bahremand; Mehdi Ghasemi; Mehdi Gharghabi; Ahmad Reza Dehpour
Journal:  J Epilepsy Res       Date:  2021-06-30

Review 9.  Drug-Resistant Epilepsy: Multiple Hypotheses, Few Answers.

Authors:  Fei Tang; Anika M S Hartz; Björn Bauer
Journal:  Front Neurol       Date:  2017-07-06       Impact factor: 4.003

Review 10.  Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management.

Authors:  Chitra Rawat; Samiksha Kukal; Ujjwal Ranjan Dahiya; Ritushree Kukreti
Journal:  J Neuroinflammation       Date:  2019-10-30       Impact factor: 8.322

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.